abstract |
The present invention relates to novel sulfonamides of general formula (I) (wherein the substituents R 1 , R 2 , R 3 , R 4 , A and X have the prescribed meanings), processes for their preparation and in particular It relates to their use as antiviral agents against cytomegalovirus. [Chemical 1] |